Developer docs
API playgroundTry for free, no card

Search company profiles

Outaouais Memory Clinic

Full company profile

uuid0021xw8

Namestring
Outaouais Memory Clinic
Legal namestring
Clinique Mémoire
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Outaouais Memory Clinic (La Clinique de la Mémoire) is a privately held Canadian specialty clinical research organization that operates bilingual memory evaluation and Alzheimer's clinical trial clinics in Ottawa (headquarters, 1600 Avenue Carling) and Montréal (1300 rue Sherbrooke Ouest), with a third Ottawa-area site consolidated in 2024. Founded in 2012 by psychiatrist and neuroscientist Dr. Richard Bergeron, the clinic serves adults aged 50 and older concerned about cognitive decline, offering free, confidential in-clinic memory evaluations that combine psychometric testing (MMSE, MoCA, Trails A&B), ApoE genetic screening, and referrals to biomarker workups (PET, MRI, lumbar puncture CSF) delivered through partner imaging centers ResoScan and IRM Saint-Joseph. Evaluations feed directly into the clinic's core Alzheimer's and mild cognitive impairment clinical trials program, which has executed more than 102 Phase I-IV studies since 2012 on behalf of biotech and pharmaceutical sponsors, supported by an on-site research pharmacy (Hôpital de jour), a sample-preparation laboratory, and an in-house electronic research management system (eSource/eRegulatory) calibrated for cognitive disorder trials.

The clinic's technology stack is clinical-operational rather than software-product in nature: the proprietary eSource/eRegulatory platform grants sponsors real-time access to study data, while patient-facing tools include a public online five-word memory self-test (launched December 2022) and a recurring monthly educational webinar series, 'Les jasettes du premier jeudi,' delivered on Microsoft Teams. Revenue is generated almost exclusively through professional-services contracts with biotech and pharmaceutical trial sponsors who fund all clinical procedures, allowing the clinic to provide evaluations and trial participation at no cost to patients; no pricing or rate cards are publicly disclosed. Go-to-market combines direct-to-consumer acquisition (website forms, phone, email, free self-test) with referral partnerships — notably Société Alzheimer Outaouais, Société Alzheimer de Montréal, and the Douglas/McGill research network — and enterprise business development targeting North American academic and industry sponsors.

The operating footprint is purely domestic (Ontario and Québec), the workforce of 51-100 spans physicians, specialized nurses, psychometricians, pharmacists, and laboratory technologists, and the company is closely held with no disclosed institutional investors or funding rounds. Recent strategic momentum includes the November 2024 opening of the Montréal clinic, the June 2024 consolidation of the Outaouais and Ottawa operations, and demand tailwinds from Health Canada approvals of Lecanemab (October 2025) and Donanemab (May 2026), which materially expand the addressable disease-modifying Alzheimer's therapy market in Canada.

Short descriptiontext

Outaouais Memory Clinic is a privately held bilingual Canadian specialty research organization that provides free memory evaluations for adults 50+ and conducts Phase I-IV Alzheimer's clinical trials on behalf of biotech and pharmaceutical sponsors across its Ottawa and Montréal clinics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersOttawa, Canada
HQ citystring
Ottawa
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
Alzheimer's clinical research, memory evaluation services, cognitive clinical trials, biomarker diagnostic services, neurodegenerative disease research
Industry3 codes
1Cognitive & Behavioral Neurology (Dementia/Memory Disorders)
CodeHLAKAIAHPrimaryYes
2Memory Care Care Management & Navigation (Dementia Care Coordination)
CodeHLADACAJPrimaryNo
3Alzheimer’s Specialized Care (Mid/Late-Stage)
CodeHSABAEACPrimaryNo
NAICS code3 codes
  • Services for the Elderly and Persons with Disabilities62412
  • Services for the Elderly and Persons with Disabilities624120
  • Offices of Mental Health Practitioners (except Physicians)621330
SIC code2 codes
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Home Health Care Services8082
Product category
Clinical Research Services
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical trial services for biotech/pharmaceutical sponsors
TypeProfessional Services
Description

Contract research revenue from pharmaceutical and biotechnology sponsors who fund Phase II/III Alzheimer's and cognitive disorder trials managed end-to-end by the clinic (patient recruitment, biomarker collection, psychometric evaluations, regulatory compliance). Sponsors cover all clinical procedures so evaluations remain free for participants.

cliniquememoire.ca
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Pricing details1 tier
1Free memory evaluation and clinical trial participation for patients
ModelOtherBilling cadencePay-as-you-go
Notes

No cost to patients; services funded by clinical trial sponsors.

cliniquememoire.ca
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Outaouais Memory Clinic (La Clinique de la Mémoire) provides free, confidential in-clinic cognitive evaluations for adults 50+ concerned about memory loss, paired with end-to-end Phase I–IV Alzheimer's and mild cognitive impairment clinical trial services conducted on behalf of pharmaceutical and biotech sponsors. The clinic combines neuropsychometric testing, biomarker workups (PET, MRI, lumbar puncture, ApoE genetics), and an integrated clinical research platform under a single bilingual operation across its Ottawa and Montréal sites.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • More than 102 clinical studies conducted since 2012
+3 more records
Product overview1 text field

Clinique de la Mémoire operates a single integrated service offering rather than a multi-product platform: a clinical-research practice that pairs free, confidential in-clinic memory evaluations (Évaluation initiale) with an Alzheimer's clinical-trials program (Phases I–IV) conducted across its Ottawa and Montréal sites, complemented by a public web-based awareness tool (Testez votre mémoire), a recurring educational webinar series (Les jasettes du premier jeudi), and a curated caregiver/patient resources directory (Ressources). The evaluations feed directly into participant screening for the clinical-trials program, which is the clinic's core research engine and the anchor service for the surrounding support, education and self-assessment modules.

Product and service3 records
1Memory Evaluations (Évaluation initiale)
CategoryDiagnostic cognitive evaluation
Description

Free, confidential in-clinic cognitive evaluations for people aged 50+ (and <50 with family history), combining medical questionnaire, medication review, lifestyle questions, cognitive testing (MMSE, MoCA, Trails A&B, Clock), AVQ/AVD assessment and optional ApoE genetic screening to determine potential eligibility for clinical research programs.

2Clinical Trials Program (Phases I–IV)
CategoryContract clinical research
Description

Conduct of Phase I, II, III and IV Alzheimer's and mild cognitive impairment clinical trials on behalf of academic and biotech/pharma sponsors, with on-site pharmacy, sample-preparation laboratory, calibrated research equipment and an electronic research management system (eSource, eRegulatory) granting sponsors real-time access to study data.

3Caregiver and Patient Resources Hub (Ressources)
CategoryPatient and caregiver support
Description

Curated directory of regional resources in Quebec and Ontario for caregivers and persons affected by cognitive disorders, covering financial, psychological, physical-activity, nutrition, transportation, housing, legal and education services, plus partner content from L'Appui, the Alzheimer Society and Bruyère.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeGTM or Marketing Partner
Description

Community partner that refers worried individuals and families to the clinic for memory evaluations. Co-organizes monthly webinar 'Les Jasettes du premier jeudi' as a featured partner. The clinic supports the Society's outreach mission in the Outaouais region.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Fundraising beneficiary and referral partner in the Greater Montréal area. The clinic's Montréal location supports the Society's mission, with awareness campaigns and donations channeled through the partner.

Strategic tierCoreTypeTechnology or Integration
Description

Private medical imaging partner providing PET and MRI scans ordered by the clinic as part of cognitive evaluations and clinical trial protocols.

Strategic tierCoreTypeTechnology or Integration
Description

Private imaging center partner delivering MRI services to clinic patients; the clinic coordinates anesthesiologists who operate in the facility to support imaging procedures.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partner with Dr Véronique Bohbot cited as collaborator on the clinic's scientific advisory/webinar work; supports cognitive neuroscience research underlying the clinic's evaluation protocols.

6More than 35 academic scientific partners and biotech collaborators
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Network of academic scientific partners across North America and biotech companies that co-design and execute Phase II/III Alzheimer's and cognitive disorder clinical trials managed by the clinic.

cliniquememoire.ca
Strategic tierMinorTypeGTM or Marketing Partner
Description

Co-presenter on the monthly 'Jasettes du premier jeudi' webinar series, contributing senior-living and home-care expertise alongside the clinic's clinical content.

8Centre d'action bénévole de Gatineau
Strategic tierMinorTypeGTM or Marketing Partner
Description

Co-presenter on monthly community webinars, helping the clinic reach Gatineau-area volunteers and seniors.

cliniquememoire.ca
Strategic tierMinorTypeGTM or Marketing Partner
Description

Major Quebec media outlet that has featured the clinic and its research mission in editorial coverage, providing earned-media visibility for the brand and clinical trial recruitment.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large global CRO with established Alzheimer's and neurodegeneration trial capabilities. Comparable as a broad incumbent serving the same biotech and pharma sponsors, but operating a portfolio of therapeutic areas rather than a memory-clinic specialty.

TypeEmerging player
Description

Cognitive assessment technology company providing computerized neuropsychological testing used in Alzheimer's and CNS trials. Comparable as a domain-specialized enabler serving the same trial sponsors and addressing the same psychometric evaluation workflows the clinic performs in-house.

TypeEmerging player
Description

Provider of tau PET imaging ligands used in Alzheimer's disease clinical trials and research. Comparable as a domain-specialized partner that supplies biomarker infrastructure overlapping with the clinic's PET-based evaluation capabilities.

TypeBroad incumbent
Description

Global CRO operating dedicated CNS and neuroscience trial networks including Alzheimer's programs. Comparable as a broad incumbent that competes for the same sponsor Phase II/III Alzheimer's contracts but at much larger scale and with multi-country site coverage.

TypeBroad incumbent
Description

Global biopharmaceutical services organization running CNS clinical trials. Comparable as a broad incumbent that competes for sponsor Alzheimer's protocols, with broader therapeutic coverage and deeper global site network.

TypeEmerging player
Description

Diagnostics company offering blood-based biomarkers (PrecivityAD) for Alzheimer's detection used in clinical research and increasingly in trial enrollment. Adjacent to the clinic's CSF/lumbar puncture biomarker workflow as trials shift toward less invasive screening.

TypeOthers
Description

Clinical trial technology and imaging core lab provider supporting CNS and Alzheimer's trials, including eCOA and MRI/PET imaging analysis. Adjacent to the clinic's operations as a technology vendor and potential partner rather than a direct competitor for trial services.

TypeRegional player
Description

Montreal-headquartered Canadian CRO offering clinical trial management and patient recruitment services. Comparable as a domestic competitor bidding on the same biotech and pharma trial contracts in the Canadian neurology and CNS space.

TypeRegional player
Description

Canadian full-service CRO with clinical operations in Montreal and across North America. Comparable as a domestic trial-services peer that competes for CNS and early-phase sponsor work, though Altasciences operates at broader scale and across therapeutic areas.

TypeDirect peer
Description

A Canadian memory clinic and Alzheimer's clinical research site operating in Toronto with a similar model of integrating specialist cognitive evaluations with Phase II/III industry-sponsored trials. Directly comparable in patient population, sponsor relationships, and trial services offering.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Outaouais Memory Clinic

Clinical Research Servicescliniquememoire.ca

Outaouais Memory Clinic is a privately held bilingual Canadian specialty research organization that provides free memory evaluations for adults 50+ and conducts Phase I-IV Alzheimer's clinical trials on behalf of biotech and pharmaceutical sponsors across its Ottawa and Montréal clinics.

What Outaouais Memory Clinic does

Outaouais Memory Clinic (La Clinique de la Mémoire) is a privately held Canadian specialty clinical research organization that operates bilingual memory evaluation and Alzheimer's clinical trial clinics in Ottawa (headquarters, 1600 Avenue Carling) and Montréal (1300 rue Sherbrooke Ouest), with a third Ottawa-area site consolidated in 2024. Founded in 2012 by psychiatrist and neuroscientist Dr. Richard Bergeron, the clinic serves adults aged 50 and older concerned about cognitive decline, offering free, confidential in-clinic memory evaluations that combine psychometric testing (MMSE, MoCA, Trails A&B), ApoE genetic screening, and referrals to biomarker workups (PET, MRI, lumbar puncture CSF) delivered through partner imaging centers ResoScan and IRM Saint-Joseph. Evaluations feed directly into the clinic's core Alzheimer's and mild cognitive impairment clinical trials program, which has executed more than 102 Phase I-IV studies since 2012 on behalf of biotech and pharmaceutical sponsors, supported by an on-site research pharmacy (Hôpital de jour), a sample-preparation laboratory, and an in-house electronic research management system (eSource/eRegulatory) calibrated for cognitive disorder trials.

The clinic's technology stack is clinical-operational rather than software-product in nature: the proprietary eSource/eRegulatory platform grants sponsors real-time access to study data, while patient-facing tools include a public online five-word memory self-test (launched December 2022) and a recurring monthly educational webinar series, 'Les jasettes du premier jeudi,' delivered on Microsoft Teams. Revenue is generated almost exclusively through professional-services contracts with biotech and pharmaceutical trial sponsors who fund all clinical procedures, allowing the clinic to provide evaluations and trial participation at no cost to patients; no pricing or rate cards are publicly disclosed. Go-to-market combines direct-to-consumer acquisition (website forms, phone, email, free self-test) with referral partnerships — notably Société Alzheimer Outaouais, Société Alzheimer de Montréal, and the Douglas/McGill research network — and enterprise business development targeting North American academic and industry sponsors.

The operating footprint is purely domestic (Ontario and Québec), the workforce of 51-100 spans physicians, specialized nurses, psychometricians, pharmacists, and laboratory technologists, and the company is closely held with no disclosed institutional investors or funding rounds. Recent strategic momentum includes the November 2024 opening of the Montréal clinic, the June 2024 consolidation of the Outaouais and Ottawa operations, and demand tailwinds from Health Canada approvals of Lecanemab (October 2025) and Donanemab (May 2026), which materially expand the addressable disease-modifying Alzheimer's therapy market in Canada.

Outaouais Memory Clinic firmographics

Firmographics
Name
Outaouais Memory Clinic
Legal name
Clinique Mémoire
Website
https://cliniquememoire.ca
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Short description
Outaouais Memory Clinic is a privately held bilingual Canadian specialty research organization that provides free memory evaluations for adults 50+ and conducts Phase I-IV Alzheimer's clinical trials on behalf of biotech and pharmaceutical sponsors across its Ottawa and Montréal clinics.
Ownership category
akta.pro rank

Outaouais Memory Clinic industry classification

Industry
Product category
Clinical Research Services
NAICS
Services for the Elderly and Persons with Disabilities (62412), Services for the Elderly and Persons with Disabilities (624120), Offices of Mental Health Practitioners (except Physicians) (621330)
SIC
Services-Specialty Outpatient Facilities, Nec (8093), Services-Home Health Care Services (8082)
akta.pro primary industry
Cognitive & Behavioral Neurology (Dementia/Memory Disorders) (HLAKAIAH)
akta.pro secondary industries
Memory Care Care Management & Navigation (Dementia Care Coordination) (HLADACAJ), Alzheimer’s Specialized Care (Mid/Late-Stage) (HSABAEAC)

Keywords

  • Alzheimer's clinical research
  • Memory evaluation services
  • Cognitive clinical trials
  • Biomarker diagnostic services
  • Neurodegenerative disease research

Where Outaouais Memory Clinic is headquartered

Location

Headquarters

HQ city
Ottawa
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

Outaouais Memory Clinic business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Clinical trial services for biotech/pharmaceutical sponsors: Contract research revenue from pharmaceutical and biotechnology sponsors who fund Phase II/III Alzheimer's and cognitive disorder trials managed end-to-end by the clinic (patient recruitment, biomarker collection, psychometric evaluations, regulatory compliance). Sponsors cover all clinical procedures so evaluations remain free for participants.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goFree memory evaluation and clinical trial participation for patients

Go-to-market motion4 records

Distribution channels5 records

Marketing channels9 records

Outaouais Memory Clinic product offering

Product offering

Core offering

Outaouais Memory Clinic (La Clinique de la Mémoire) provides free, confidential in-clinic cognitive evaluations for adults 50+ concerned about memory loss, paired with end-to-end Phase I–IV Alzheimer's and mild cognitive impairment clinical trial services conducted on behalf of pharmaceutical and biotech sponsors. The clinic combines neuropsychometric testing, biomarker workups (PET, MRI, lumbar puncture, ApoE genetics), and an integrated clinical research platform under a single bilingual operation across its Ottawa and Montréal sites.

Product overview

Clinique de la Mémoire operates a single integrated service offering rather than a multi-product platform: a clinical-research practice that pairs free, confidential in-clinic memory evaluations (Évaluation initiale) with an Alzheimer's clinical-trials program (Phases I–IV) conducted across its Ottawa and Montréal sites, complemented by a public web-based awareness tool (Testez votre mémoire), a recurring educational webinar series (Les jasettes du premier jeudi), and a curated caregiver/patient resources directory (Ressources). The evaluations feed directly into participant screening for the clinical-trials program, which is the clinic's core research engine and the anchor service for the surrounding support, education and self-assessment modules.

Differentiator

Problem solved

Functional benefit

Products and services

  • Memory Evaluations (Évaluation initiale) Free, confidential in-clinic cognitive evaluations for people aged 50+ (and <50 with family history), combining medical questionnaire, medication review, lifestyle questions, cognitive testing (MMSE, MoCA, Trails A&B, Clock), AVQ/AVD assessment and optional ApoE genetic screening to determine potential eligibility for clinical research programs.
  • Clinical Trials Program (Phases I–IV) Conduct of Phase I, II, III and IV Alzheimer's and mild cognitive impairment clinical trials on behalf of academic and biotech/pharma sponsors, with on-site pharmacy, sample-preparation laboratory, calibrated research equipment and an electronic research management system (eSource, eRegulatory) granting sponsors real-time access to study data.
  • Caregiver and Patient Resources Hub (Ressources) Curated directory of regional resources in Quebec and Ontario for caregivers and persons affected by cognitive disorders, covering financial, psychological, physical-activity, nutrition, transportation, housing, legal and education services, plus partner content from L'Appui, the Alzheimer Society and Bruyère.

Quantifiable outcome

  • More than 102 clinical studies conducted since 2012
  • +3 more outcomes

Companies that use Outaouais Memory Clinic

Customer profile

Segments4 records

Ideal customer profiles4 records

Outaouais Memory Clinic technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Outaouais Memory Clinic partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • Société Alzheimer OutaouaiscoreGTM or Marketing PartnerCommunity partner that refers worried individuals and families to the clinic for memory evaluations. Co-organizes monthly webinar 'Les Jasettes du premier jeudi' as a featured partner. The clinic supports the Society's outreach mission in the Outaouais region.
  • Société Alzheimer de MontréalcoreGTM or Marketing PartnerFundraising beneficiary and referral partner in the Greater Montréal area. The clinic's Montréal location supports the Society's mission, with awareness campaigns and donations channeled through the partner.
  • ResoScancoreTechnology or IntegrationPrivate medical imaging partner providing PET and MRI scans ordered by the clinic as part of cognitive evaluations and clinical trial protocols.
  • IRM Saint-JosephcoreTechnology or IntegrationPrivate imaging center partner delivering MRI services to clinic patients; the clinic coordinates anesthesiologists who operate in the facility to support imaging procedures.
  • Centre de recherche de l'Hôpital Douglas / Université McGillcoreStrategic or Co-development PartnerAcademic research partner with Dr Véronique Bohbot cited as collaborator on the clinic's scientific advisory/webinar work; supports cognitive neuroscience research underlying the clinic's evaluation protocols.
  • More than 35 academic scientific partners and biotech collaboratorscoreStrategic or Co-development PartnerNetwork of academic scientific partners across North America and biotech companies that co-design and execute Phase II/III Alzheimer's and cognitive disorder clinical trials managed by the clinic.
  • Bien Chez SoiminorGTM or Marketing PartnerCo-presenter on the monthly 'Jasettes du premier jeudi' webinar series, contributing senior-living and home-care expertise alongside the clinic's clinical content.
  • Centre d'action bénévole de GatineauminorGTM or Marketing PartnerCo-presenter on monthly community webinars, helping the clinic reach Gatineau-area volunteers and seniors.
  • La PresseminorGTM or Marketing PartnerMajor Quebec media outlet that has featured the clinic and its research mission in editorial coverage, providing earned-media visibility for the brand and clinical trial recruitment.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Outaouais Memory Clinic competitors and assessment

Company assessment

Broad incumbents

  • Parexel: Large global CRO with established Alzheimer's and neurodegeneration trial capabilities. Comparable as a broad incumbent serving the same biotech and pharma sponsors, but operating a portfolio of therapeutic areas rather than a memory-clinic specialty.
  • ICON plc: Global CRO operating dedicated CNS and neuroscience trial networks including Alzheimer's programs. Comparable as a broad incumbent that competes for the same sponsor Phase II/III Alzheimer's contracts but at much larger scale and with multi-country site coverage.
  • Syneos Health: Global biopharmaceutical services organization running CNS clinical trials. Comparable as a broad incumbent that competes for sponsor Alzheimer's protocols, with broader therapeutic coverage and deeper global site network.

Emerging players

  • Cogstate: Cognitive assessment technology company providing computerized neuropsychological testing used in Alzheimer's and CNS trials. Comparable as a domain-specialized enabler serving the same trial sponsors and addressing the same psychometric evaluation workflows the clinic performs in-house.
  • Cerveau Technologies: Provider of tau PET imaging ligands used in Alzheimer's disease clinical trials and research. Comparable as a domain-specialized partner that supplies biomarker infrastructure overlapping with the clinic's PET-based evaluation capabilities.
  • C2N Diagnostics: Diagnostics company offering blood-based biomarkers (PrecivityAD) for Alzheimer's detection used in clinical research and increasingly in trial enrollment. Adjacent to the clinic's CSF/lumbar puncture biomarker workflow as trials shift toward less invasive screening.

Others

  • Clario: Clinical trial technology and imaging core lab provider supporting CNS and Alzheimer's trials, including eCOA and MRI/PET imaging analysis. Adjacent to the clinic's operations as a technology vendor and potential partner rather than a direct competitor for trial services.

Regional players

  • JSS Medical Research: Montreal-headquartered Canadian CRO offering clinical trial management and patient recruitment services. Comparable as a domestic competitor bidding on the same biotech and pharma trial contracts in the Canadian neurology and CNS space.
  • Altasciences: Canadian full-service CRO with clinical operations in Montreal and across North America. Comparable as a domestic trial-services peer that competes for CNS and early-phase sponsor work, though Altasciences operates at broader scale and across therapeutic areas.

Direct peers

  • Toronto Memory Program: A Canadian memory clinic and Alzheimer's clinical research site operating in Toronto with a similar model of integrating specialist cognitive evaluations with Phase II/III industry-sponsored trials. Directly comparable in patient population, sponsor relationships, and trial services offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Outaouais Memory Clinic social profiles

Digital presence

Outaouais Memory Clinic compliance and trust

Trust signal

Compliance2 records

Outaouais Memory Clinic financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Outaouais Memory Clinic leadership team

Management profile

Number of profiles

Profiles13 records

Outaouais Memory Clinic subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Outaouais Memory Clinic funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Outaouais Memory Clinic M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Outaouais Memory Clinic

What does Outaouais Memory Clinic do?

Outaouais Memory Clinic (La Clinique de la Mémoire) provides free, confidential in-clinic cognitive evaluations for adults 50+ concerned about memory loss, paired with end-to-end Phase I–IV Alzheimer's and mild cognitive impairment clinical trial services conducted on behalf of pharmaceutical and biotech sponsors. The clinic combines neuropsychometric testing, biomarker workups (PET, MRI, lumbar puncture, ApoE genetics), and an integrated clinical research platform under a single bilingual operation across its Ottawa and Montréal sites.

Is Outaouais Memory Clinic a public or private company?

Outaouais Memory Clinic is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Outaouais Memory Clinic founded?

Outaouais Memory Clinic was founded in 2012. It employs 51 to 100 people.

Where is Outaouais Memory Clinic based?

Outaouais Memory Clinic is headquartered in Ottawa, Canada, in the North America region.

How does Outaouais Memory Clinic make money?

One revenue line is on record: clinical trial services for biotech/pharmaceutical sponsors.

Who are Outaouais Memory Clinic's main competitors?

Broad incumbents on record are Parexel, ICON plc and Syneos Health. Emerging players are Cogstate, Cerveau Technologies and C2N Diagnostics. Clario is listed as an others. Regional players are JSS Medical Research and Altasciences. Toronto Memory Program is listed as a direct peer.

Does Outaouais Memory Clinic have an API?

No public API is recorded for Outaouais Memory Clinic.

What industry is Outaouais Memory Clinic in?

Outaouais Memory Clinic's product category is Clinical Research Services. Its primary akta.pro industry code is HLAKAIAH, Cognitive & Behavioral Neurology (Dementia/Memory Disorders), with a secondary code of HLADACAJ, Memory Care Care Management & Navigation (Dementia Care Coordination). Its NAICS code is 62412 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales